Head-to-head comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study

Wenjia Zhu; Yuejuan Cheng; Xuezhu Wang; Shaobo Yao; Ru Jia; Jianming Xu; Chunmei Bai; Hong Zhao; Li Huo

doi:10.2967/jnumed.119.235093

OtherClinical Investigations (Human)

Head-to-head comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study

Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Ru Jia, Jianming Xu, Chunmei Bai, Hong Zhao and Li Huo

Journal of Nuclear Medicine November 2019, jnumed.119.235093; DOI: https://doi.org/10.2967/jnumed.119.235093

Wenjia Zhu

1 Peking Union Medical College Hospital, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yuejuan Cheng

1 Peking Union Medical College Hospital, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xuezhu Wang

1 Peking Union Medical College Hospital, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shaobo Yao

2 Tianjin Medical University General Hospital, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ru Jia

3 The fifthMedical Center, General Hospital of PLA, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jianming Xu

4 The fifth Medical Center, General Hospital of PLA, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chunmei Bai

1 Peking Union Medical College Hospital, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hong Zhao

5 Chinese Academy of Medical Sciences and Peking Union Medical College, China;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Li Huo

6 Peking Union Medical College hospital, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 10

October 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Head-to-head comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Head-to-head comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study

Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Ru Jia, Jianming Xu, Chunmei Bai, Hong Zhao, Li Huo

Journal of Nuclear Medicine Nov 2019, jnumed.119.235093; DOI: 10.2967/jnumed.119.235093

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Head-to-head comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study

Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Ru Jia, Jianming Xu, Chunmei Bai, Hong Zhao, Li Huo

Journal of Nuclear Medicine Nov 2019, jnumed.119.235093; DOI: 10.2967/jnumed.119.235093

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

SSTR Antagonists as Theranostic Option in Merkel Cell Carcinoma
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study
Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study
The Emergence of Somatostatin Antagonist-Based Theranostics: Paving the Road Toward Another Success?
18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
A Prospective, Randomized, Double-Blind Study to Evaluate the Safety, Biodistribution, and Dosimetry of 68Ga-NODAGA-LM3 and 68Ga-DOTA-LM3 in Patients with Well-Differentiated Neuroendocrine Tumors

Google Scholar

Keywords

neuroendocrine
PET/CT
radiopharmaceuticals
<sup>68</sup>Ga-DOTA-JR11
<sup>68</sup>Ga-DOTATATE
somatostatin receptor antagonist
neuroendocrine tumor

Main menu

User menu

Search

Head-to-head comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

Similar Articles

Keywords